The role of angiotensin-converting enzyme gene polymorphism in pulmonary thromboembolism

Numan Ekim; I. Kivilcim Oguzulgen; Nalan Demir; Buket Altinok; Nejat Akar

doi:10.1055/s-0037-1613735

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2004; 92(02): 432-433
DOI: 10.1055/s-0037-1613735

Letters to the Editor

Schattauer GmbH

The role of angiotensin-converting enzyme gene polymorphism in pulmonary thromboembolism

Numan Ekim

¹Gazi University School of Medicine Department of Pulmonary Medicine, Ankara, Turkey

,

I. Kivilcim Oguzulgen

¹Gazi University School of Medicine Department of Pulmonary Medicine, Ankara, Turkey

,

Nalan Demir

¹Gazi University School of Medicine Department of Pulmonary Medicine, Ankara, Turkey

,

Buket Altinok

²Ankara University Biotechnology Institute, Ankara, Turkey

,

Nejat Akar

³Ankara University School of Medicine Department of Paediatric Molecular Genetics, Ankara, Turkey

References
1 Koppel H, Renner W, Gugl A. et al. The angio tensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosis. Thromb Haemost 2004; 91: 76-79.
2 Akar N, Aras Ö, Ömürlü K. et al. Deletion polymorphism at the angiotensinogen converting enzyme gene in Turkish patients with coronary artery disease and controls. Scand J Clin Lab fovest 1998; 58: 491-495.
3 Akar N. Site specific mutagenesis: Usage for the mutation detection in thrombosis. Turk J Haematol 1998; 15: 123-124.
4 Rigat N, Hubert C, Alhenc-Gelas F. et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
5 Cambien F. The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin Genet 1994; 46: 94-101.
6 Cody RJ. The integrated effects of angiotensin II. Am J Cardiol 1997; 78: 297-301.
7 Wells PS, Rodger MA, Forgie MA. et al. The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism. Thromb Haemost 2003; 90: 829-834.
8 Von Depka M, Czwalinna A, Wermes C. et al. The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. Thromb Haemost 2003; 89: 847-852.
9 Delia CJValle, Issack PS, Baitaer A. et al. The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint artroplasty. BMC Musculoskelet Disord 2001; 02: 1.
10 Lu Y, Hui R, Zhao Y. Insertion/deletion polymorphism of the angiotensin I converting enzyme gene and pulmonary thromboembolism in Chinese population. Zhonghua jie He He Hu Xi Za Zhi 2001; 24: 265-268.
11 Jackson A, Brown K, Langdown J. et al. Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism. Br J Haematol 2000; 111: 562-564.
12 Gonzalez AJOrdonez, Carreira JMFernandez, Medina JMRodriguez. et al. Risk of venous thromboembolism associated with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene. Blood Coagul Fibrinolysis 2000; 11: 485-490.
13 Philipp CS, Dilley A, Saidi P. et al. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thromb Haemost 1998; 80: 869-873.
14 Dilley A, Austin H, Hooper WC. et al. Relation of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol 1998; 147: 30-35.